Genomic Health's CEO Discusses Q4 2012 Results – Earnings Call Transcript
Genomic Health's CEO Discusses Q4 2012 Results – Earnings Call Transcript
Filed under: drug treatment programs in san francisco
Specifically, this year we plan to initiate additional large DCIS clinical study to confirm and extend the findings of the landmark ECOG E-5194 study, to conduct a colon oxaliplatin treatment validation study for prediction in stage 3 disease, a large …
Read more on Seeking Alpha
Bladder cancer gets little attention, research funding
Filed under: drug treatment programs in san francisco
SAN FRANCISCO, Ca. – For at least six months, Michael Bailey's doctors assumed that the blood in his urine came from a kidney stone or a urinary tract infection. After the bleeding persisted, his doctor persuaded him to have a cystoscopy, a procedure …
Read more on KERO-TV 23
Path Names Dr. Hing Sham to Lead Drug Research and Preclinical Development
Filed under: drug treatment programs in san francisco
In his new role with PATH's drug development team, based in South San Francisco, Dr. Sham will be involved with discovery and preclinical research for PATH's drug development portfolio. He will drive the development of the existing product pipeline and …
Read more on AllAfrica.com